Indomethacin SR Pellets

Product Overview

Indomethacin SR (Sustained Release) Pellets are a modified-release oral dosage form of Indomethacin, a non-steroidal anti-inflammatory drug (NSAID). These pellets are designed to release the drug gradually over an extended period, ensuring prolonged therapeutic activity, reduced dosing frequency, and minimized gastrointestinal irritation compared to conventional formulations.

Product Name
Indomethacin SR Pellets
Strengths Available
27.5% - 40% (customizable per your offering)
CAS No. / IUPAC Name
CAS: 53-86-1; IUPAC: 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid
Molecular Formula / Weight
C19H16ClNO4 / ~357.79 g/mol
Identification
Validated HPLC (USP/BP/EP)
Release Type
Sustained Release (SR) / Controlled Release (CR); pH-triggered (optimized for intestinal release)
Applications
Capsules; tablets (used in treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute gout, and other inflammatory conditions)
Storage Conditions
Store in a tightly sealed, airtight container. Protect from direct light and high humidity. Keep in a cool, dry place.

Acetaminophen DC Granules – Typical Composition

Component	Function
Indomethacin	Active Pharmaceutical Ingredient (API)
Sugar Spheres / MCC Spheres	Inert core or starter pellets
Hydroxypropyl Methylcellulose (HPMC)	Binder / Film former during layering
Talc / Colloidal Silicon Dioxide	Anti-adherent / Glidant
Ethyl Cellulose / HPMC K15M / EC-10	Sustained release polymer (controls drug release rate)
Triethyl Citrate / PEG 6000	Plasticizer (improves flexibility of polymer coating)
Purified Water	Solvent (removed after processing)

Why Choose Pellets from Salius Pharma?

Outsourcing pellets through a trusted partner like Salius Pharma can be a strategic decision to save both time and resources, without compromising on quality or compliance. Instead, partnering with Salius Pharma—a leading distributor aligned with USFDA-approved and WHO-GMP-certified manufacturers in India—allows you to leverage high-quality products, seamless logistics, and professional support under one roof.

Key Advantages of Partnering with Salius Pharma

Cost-Efficient Setup
Avoid heavy capital investment in infrastructure and workforce.
Guaranteed Quality Assurance
Products are sourced only from certified facilities with validated processes.
Access to Advanced Technology
Benefit from the latest drug delivery systems without managing the tech in-house.
Accelerated Market Entry
Launch products faster and establish your brand in less time.
Custom Formulation Support
Flexibility to offer tailored pellet solutions as per your market needs.

Expected Delivery Time

We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.

Place an Order or Request a Quote from Salius Pharma

Looking to source Indomethacin SR Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.

Get in Touch

Email: export@saliuspharma.com
Call / WhatsApp: +91 84258 80640 / +91 84258 80643
Landline: +91 22 49700 601 / +91 22 44503 148
Corporate Office: 3104–3106, Plan S Business Park, Nerul MIDC Opp. Dr. D.Y. Patil Stadium, Navi Mumbai – 400706, Maharashtra, India

Confidentiality Notice

The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.

Any patented products are excluded from our offerings in regions where such patents are currently in force.

FAQs

Indomethacin SR Pellets are primarily used in the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute gout, and other painful inflammatory conditions.

Ethyl Cellulose, HPMC, and other controlled-release polymers are commonly used to achieve the desired release profile.

Indomethacin SR Pellets are commonly manufactured in strengths equivalent to 25 mg, 50 mg, and 75 mg, but can be customized based on formulation needs.

Yes, pelletization provides uniform drug distribution, flexible dosing, improved bioavailability, reduced dose dumping risk, and enhanced patient compliance.

Enquiry